 BALTIMORE, April 18, 2022 GLOBE NEWSWIRE -- Graybug Vision, Inc. Nasdaq: GRAY, a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of ocular diseases, today announced a platform presentation at the upcoming American Society of Cataract and Refractive Surgery ASCRS Annual Meeting, to be held in Washington, D.C. from April 22-26, 2022. 